Ticker
Reporting Basis
Period
From
To
Form Type
Report Format
Update Type


ANGIODYNAMICS   FYE=5 (May)

Annual - Income Statement - Company Specific

Fiscal period2022202120202019201820172016201520142013
Period End Date5/31/20225/31/20215/31/20205/31/20195/31/20185/31/20175/31/20165/31/20155/31/20145/31/2013
Sales316.22291.01264.16270.63261.66269.79353.89356.53354.43341.92
Total Revenues316.22291.01264.16270.63261.66269.79353.89356.53354.43341.92
Cost of sales150.49134.22113.89114.63117.80125.84179.57180.74174.25173.40
Gross Profit165.73156.79150.27156.00143.86143.95174.32175.80180.17168.51
Goodwill impairment----158.58--------------
Amortization of intangibles19.4618.1418.1217.0613.9114.5717.9617.9716.5616.62
Research and development30.7436.3929.6828.2624.3424.1525.0526.5928.1226.32
General and Administrative38.4535.9237.8734.9030.9931.1330.5830.0326.9026.19
Sales and marketing95.3081.3178.6376.8373.1174.8783.7482.3585.3176.12
Restructuring and other costs, net--------------------
Acquisition and other non-recurring9.0420.236.0115.1315.4327.5112.5926.2610.8713.80
Litigation provisions, net--------------------
Change in fair value of contingent consideration(1.21)(0.09)11.536.78(0.25)15.26(0.95)8.101.91(1.58)
Medical device excise tax----------1.84(2.42)(4.14)(3.83)(1.60)
Total Operating Expenses194.20192.07317.37165.40158.03155.13173.30179.25169.69162.23
Operating Income (Loss)(28.47)(35.28)(167.10)(9.40)(14.17)(11.18)1.02(3.45)10.496.29
Interest expense0.690.860.915.103.062.843.393.193.665.27
Impairment loss on investment--------------------
Interest income------------------0.10
Other income (loss)(0.79)0.09(0.13)(0.21)(0.03)(0.28)(0.89)(1.49)(1.65)(2.71)
Total other (expenses) income, net(1.48)(0.77)(1.04)(5.31)(3.09)(3.12)(4.27)(4.68)(5.30)(7.88)
(Loss) income before income tax provision(29.95)(36.05)(168.14)(14.70)(17.26)(14.30)(3.25)(8.13)5.19(1.59)
Deferred------(3.97)(11.11)(7.65)39.98(5.12)2.720.83
Income tax (benefit) provision(3.40)(4.50)(1.35)(3.56)(11.04)(7.24)40.34(4.74)2.84(0.38)
Current : Federal--------(0.15)--0.03(0.24)(0.13)(1.62)
Current : State and local0.120.100.100.130.150.140.100.210.10(0.05)
Current : Non U.S0.190.200.120.290.070.270.220.420.160.47
Deferred- U.S(3.42)(3.38)(1.12)--------------
Deferred- Non U.S(0.29)(1.43)(0.45)--------------
Net income (loss) from continuing operations------(11.15)(6.23)(7.05)--------
Income from discontinued operations, net of income tax------72.4922.5612.06--------
Net income available to Common Shareholders(26.55)(31.55)(166.79)61.3416.345.01(43.59)(3.39)2.35(1.21)
Basic Earnings (Loss) Per Share From Continuing Operations------(0.30)(0.17)(0.19)--------
Basic Earnings per Share from Discontinued Operations------1.930.610.33--------
Net Earnings Per Share (Basic)(0.68)(0.82)(4.39)1.640.440.14(1.21)(0.09)0.07(0.03)
Diluted Earnings (Loss) Per Share From Continuing Operations------(0.30)(0.17)(0.19)--------
Diluted Earnings per Share from Discontinued Operations------1.930.610.33--------
Net Earnings Per Share (Diluted)(0.68)(0.82)(4.39)1.640.440.14(1.21)(0.09)0.07(0.03)
Weighted Average Shares Outstanding (Basic)39.0138.3437.9637.4937.0836.6236.1635.6835.1434.82
Weighted Average Shares Outstanding (Diluted)39.0138.3437.9637.4937.0836.6236.1635.6835.4434.82